Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

BACKGROUND: The five-tiered Cambridge Prognostic Group (CPG) classification is a better predictor of prostate cancer-specific mortality than the traditional three-tiered classification (low, intermediate, and high risk). We investigated radical treatment rates according to CPG in men diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Parry, M. G., Cowling, T. E., Sujenthiran, A., Nossiter, J., Berry, B., Cathcart, P., Aggarwal, A., Payne, H., van der Meulen, J., Clarke, N. W., Gnanapragasam, V. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254634/
https://www.ncbi.nlm.nih.gov/pubmed/32460859
http://dx.doi.org/10.1186/s12916-020-01588-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254634/
https://www.ncbi.nlm.nih.gov/pubmed/32460859
http://dx.doi.org/10.1186/s12916-020-01588-9

Ejemplares similares